切換帳號

  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 登入

全站搜尋

台灣泌尿科醫學會E-School
  • 登入
  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 到官網
  • Home
  • 到官網
  • Home
知識庫
  • 目錄總覽
  • 文件總覽
  • 最新討論
目錄 / 資料夾
  • 學術活動與演講
    • 年會
      • 2026半年會
        • 摘要
      • 2025年會 (UAA)
        • 摘要
      • 2025半年會
        • 摘要
      • 2024年會
        • 摘要
      • 2024半年會
        • 摘要
      • 2023年會
        • 摘要
      • 2023半年會
        • 摘要
      • 2022年會
        • 摘要
      • 2021年會
        • 摘要
      • 2021半年會
        • 摘要
      • 2020年會
        • 摘要
      • 2020半年會
        • 摘要
      • 2019年會
        • 摘要
      • 2019半年會
        • 摘要
      • 2018年會
        • 摘要
      • 2018半年會
        • 摘要
      • 2017年會
        • 摘要
      • 2017半年會
        • 摘要
      • 2016年會
        • 摘要
      • 2016半年會
        • 摘要
      • 2015年會
        • 摘要
  • 新手指南與FAQ
  1. 知識庫
  2. 最新上傳

最新上傳
(
  • 熱門
)

最新上傳

(
  • 熱門
)
MP05-07: Demethoxycurcumin induces apoptosis in HER2 overexpressing bladder cancer cells through degradation of HER2 and inhibiting the PI3K/Akt pathway
2022-06-07
MP05-06: Validation of neutrophil to lymphocyte ratio for prognosis and treatment selection in muscle invasive bladder cancer: A single-institutional longitudinal study
2022-06-07
MP05-05: Clinical outcomes of plasmacytoid urothelial carcinoma of urinary bladder: A single institution experience
2022-06-07
MP05-04: Effect of Metformin on overall survival of upper tract urothelial carcinoma in patients with type 2 diabetes
2022-06-07
MP05-03: Influence of novel inflammatory biomarkers on prediction for patients with upper tract urothelial carcinoma
2022-06-07
MP05-02: Melatonin suppresses tumor malignancy through the NF-KB/P65/HIF-1a pathway in urothelial carcinoma
2022-06-07
MP05-01: Survival impact of nephroureterectomy for de novo stage IV (nonmetastatic and metastatic) upper tract urothelial carcinoma
2022-06-07
MP04-10: Risk factors of infectious complications after retrograde intrarenal surgery with holmium laser for renal stones
2022-06-07
MP04-09: Comparison of the clinical outcome and treatment cost of proximal ureteral stone removal requiring multiple initial ureteroscopic lithotripsy or extracorporeal shock wave lithotripsy procedures
2022-06-07
MP04-08: Experimental observation of isolative efficacy of solid coupling medium in extracorporeal shock wave lithotripsy
2022-06-07
MP04-07: The impact of secondhand smoke on the development of kidney stone disease is not inferior to that of smoking
2022-06-07
MP04-06: Can hounsfield unit of preoperative non-contrast computed tomography be used to predict calcium urinary stone composition?
2022-06-07
MP04-05: Betel nut chewing is related to the risk of kidney stone disease
2022-06-07
MP04-04: The impact of climate factors on the prevalence of urolithiasis and the trend of the urinary stone disease management in southern Taiwan
2022-06-07
MP04-03: Analysis of renal hematoma after extracorporeal shock wave lithotripsy
2022-06-07
MP04-02: Genetic polymorphisms of MnSOD modify the impacts of environmental melamine on oxidative stress and early kidney injury in calcium urolithiasis patients
2022-06-07
MP04-01: A novel prediction of uric acid component in nephrolithiasis using simple clinical information: A machine learning-based model
2022-06-07
MP03-10: Establishing predictive model of renal function after unilateral nephroureterectomy in upper tract urothelial carcinoma patients
2022-06-07
MP03-09: Second primary malignancy risk in patients with upper urinary tract urothelial carcinoma in Taiwan - a nationwide population-based study
2022-06-07
MP03-08: Blockade of the autophagic flux suppresses antitumor immunity via programmed death ligand-1 up-regulation in bladder cancer
2022-06-07
MP03-07: The role of lymph node dissection in patients with upper tract urothelial carcinoma without clinical lymph node metastasis undergoing radical nephroureterectomy
2022-06-07
MP03-06: Effects of variant histology on the oncology outcomes of patients with upper tract urothelial carcinoma after radical nephroureterectomy
2022-06-07
MP03-05: Aquaporins are involved in tumor formation and may potentially act as a therapeutic target in urothelial carcinoma
2022-06-07
MP03-04: Cost-effectiveness analysis of immune checkpoint inhibitors in metastatic urothelial cancer, a single-center retrospective study
2022-06-07
  • <
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • >
/ 155
地址:台北市 11051 信義區基隆路一段432號6樓之1, 電話:02-2729-0819, 傳真:02-2729-0864
網址: http://eschool.tua.org.tw,  EMail: eschool@tua.org.tw